EU watchdog finds no link of swine flu drug and narcolepsy
Saturday 25 September 2010
The European Medicines Agency said Thursday it had found no link between the Pandemrix swine flu vaccine and the sleeping disorder narcolepsy amid patient concerns, notably in Scandinavia.
The EMA "concluded that the available evidence was insufficient to determine whether there is any link between Pandemrix and reports of narcolepsy, and that further studies were necessary to fully understand this issue", a statement said.
"The ongoing review is complex and will take some three to six months to complete," the London-based body added.
Narcolepsy is a condition in which sufferers suddenly fall into a deep sleep.
Pandemrix - produced by British pharmaceutical company GlaxoSmithKline - has been used since September 2009 for vaccination against H1N1 influenza.
The EMA added on Thursday that it had so far received 81 reports from healthcare professionals suggestive of narcolepsy, including 34 from Sweden, 30 from Finland and 10 from France.
Life & Style blogs
The future of sex: The first female condoms were derided, mistrusted and shunned - but will their modern counterparts catch on?
'It's brusquely intimate': A bereaved daughter tackles the task of emptying her father's flat
Fenwicks department store withdraws Boy London clothing over 'Nazi' eagle logo complaints
Study suggests that 'gaydars' are real - at least for women
International Women's Day 2014: Google compiles celebratory video to mark the day
- 1 The future of sex: The first female condoms were derided, mistrusted and shunned - but will their modern counterparts catch on?
- 2 South African rhino finally put down after roaming Kruger park for days with horn hacked off and bullet in brain
- 3 Italian pensioner hires an escort who turns out to be his son's girlfriend
- 4 Orgasm machine to deliver climax at the push of a button
- 5 Liam Neeson turned down James Bond role to marry Natasha Richardson
£12000 per annum: Inspiring Interns: A small but growing chain of boutique hot...
£12000 per annum: Inspiring Interns: The company works with Tier 1 FTSE 100 Ba...
£45 - 60k Per Annum: Charter Selection: Highly profitable leisure brand, marke...
£30000 - £50000 per annum + Highly Competitive Salary: Austen Lloyd: Residenti...